Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.88 Million USD | -43.63% |
| 2022 | 8.66 Million USD | 39.21% |
| 2021 | 6.22 Million USD | -4.44% |
| 2020 | 6.51 Million USD | -27.0% |
| 2019 | 8.92 Million USD | 31.39% |
| 2018 | 6.79 Million USD | -5.08% |
| 2017 | 7.15 Million USD | 94.8% |
| 2016 | 3.67 Million USD | -1.12% |
| 2015 | 3.71 Million USD | 32.45% |
| 2014 | 2.8 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 6.06 Million USD | 24.18% |
| 2024 Q2 | 5.26 Million USD | -13.25% |
| 2023 Q3 | 5.95 Million USD | -0.8% |
| 2023 Q1 | 7.07 Million USD | -18.37% |
| 2023 Q2 | 6 Million USD | -15.08% |
| 2023 Q4 | 4.88 Million USD | -18.02% |
| 2023 FY | 4.88 Million USD | -43.63% |
| 2022 Q3 | 7.63 Million USD | -32.46% |
| 2022 FY | 8.66 Million USD | 39.21% |
| 2022 Q1 | 11.4 Million USD | 83.18% |
| 2022 Q4 | 8.66 Million USD | 13.5% |
| 2022 Q2 | 11.3 Million USD | -0.87% |
| 2021 Q4 | 6.22 Million USD | 24.03% |
| 2021 Q3 | 5.01 Million USD | -18.35% |
| 2021 FY | 6.22 Million USD | -4.44% |
| 2021 Q2 | 6.14 Million USD | 1.65% |
| 2021 Q1 | 6.04 Million USD | -7.17% |
| 2020 Q3 | 7.3 Million USD | -4.36% |
| 2020 Q2 | 7.64 Million USD | -1.89% |
| 2020 Q4 | 6.51 Million USD | -10.84% |
| 2020 FY | 6.51 Million USD | -27.0% |
| 2020 Q1 | 7.78 Million USD | -12.73% |
| 2019 Q3 | 9 Million USD | 6.38% |
| 2019 Q4 | 8.92 Million USD | -0.91% |
| 2019 Q1 | 6.52 Million USD | -3.92% |
| 2019 Q2 | 8.46 Million USD | 29.73% |
| 2019 FY | 8.92 Million USD | 31.39% |
| 2018 Q3 | 6.34 Million USD | -32.9% |
| 2018 Q2 | 9.45 Million USD | 2.3% |
| 2018 FY | 6.79 Million USD | -5.08% |
| 2018 Q1 | 9.24 Million USD | 29.17% |
| 2018 Q4 | 6.79 Million USD | 7.05% |
| 2017 Q2 | 5.97 Million USD | 9.79% |
| 2017 Q4 | 7.15 Million USD | 16.61% |
| 2017 Q1 | 5.44 Million USD | 48.28% |
| 2017 FY | 7.15 Million USD | 94.8% |
| 2017 Q3 | 6.13 Million USD | 2.61% |
| 2016 FY | 3.67 Million USD | -1.12% |
| 2016 Q3 | 3.02 Million USD | -45.46% |
| 2016 Q2 | 5.53 Million USD | 36.1% |
| 2016 Q1 | 4.06 Million USD | 9.53% |
| 2016 Q4 | 3.67 Million USD | 21.61% |
| 2015 FY | 3.71 Million USD | 32.45% |
| 2015 Q4 | 3.71 Million USD | 0.0% |
| 2014 FY | 2.8 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 90.469% |
| BrainsWay Ltd. | 15.31 Million USD | 68.101% |
| Cerus Corporation | 144.3 Million USD | 96.615% |
| Envoy Medical, Inc. | 9.4 Million USD | 48.043% |
| electroCore, Inc. | 8.94 Million USD | 45.388% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 8.555% |
| IceCure Medical Ltd | 4.24 Million USD | -15.022% |
| Inogen, Inc. | 121.38 Million USD | 95.976% |
| OrthoPediatrics Corp. | 72.56 Million USD | 93.268% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 83.486% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -53.523% |
| MaxCyte, Inc. | 36.1 Million USD | 86.471% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -164.353% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1048.652% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.504% |
| PAVmed Inc | 57.13 Million USD | 91.45% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 80.815% |
| RxSight, Inc. | 22.18 Million USD | 77.984% |
| Sight Sciences, Inc. | 46.43 Million USD | 89.48% |
| SI-BONE, Inc. | 61.05 Million USD | 91.998% |
| TELA Bio, Inc. | 59.16 Million USD | 91.744% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 95.714% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 52.66% |
| Acutus Medical, Inc. | 54.83 Million USD | 91.092% |
| Talis Biomedical Corporation | 29.22 Million USD | 83.284% |
| Spectral AI, Inc. | 12.4 Million USD | 60.608% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 78.884% |
| CVRx, Inc. | 39.28 Million USD | 87.564% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 59.149% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -101.087% |
| Bioventus Inc. | 589.79 Million USD | 99.172% |
| Venus Concept Inc. | 107.1 Million USD | 95.439% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 90.544% |
| LivaNova PLC | 1.15 Billion USD | 99.576% |
| 908 Devices Inc. | 37.49 Million USD | 86.97% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.306% |
| Nemaura Medical Inc. | 26.37 Million USD | 81.48% |
| NeuroPace, Inc. | 86.99 Million USD | 94.385% |
| LENSAR, Inc. | 22.4 Million USD | 78.201% |
| Apyx Medical Corporation | 52.31 Million USD | 90.663% |
| Cutera, Inc. | 518.12 Million USD | 99.057% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 83.344% |
| BioSig Technologies, Inc. | 4.68 Million USD | -4.269% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 91.631% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 77.266% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.777% |
| Axonics, Inc. | 82.35 Million USD | 94.069% |
| Outset Medical, Inc. | 190.91 Million USD | 97.441% |
| IRIDEX Corporation | 24.91 Million USD | 80.393% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 96.059% |
| IRadimed Corporation | 20.73 Million USD | 76.442% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -191.816% |
| INVO Bioscience, Inc. | 19.99 Million USD | 75.569% |
| Telesis Bio, Inc. | 40.87 Million USD | 88.048% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 88.024% |
| Varex Imaging Corporation | 668.6 Million USD | 99.269% |
| Quipt Home Medical Corp. | 136.29 Million USD | 96.416% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -36.758% |
| Pulmonx Corporation | 60.63 Million USD | 91.944% |
| Dynatronics Corporation | 11.78 Million USD | 58.532% |
| Modular Medical, Inc. | 2.27 Million USD | -115.009% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -20.202% |
| Semler Scientific, Inc. | 6.27 Million USD | 22.089% |
| InMode Ltd. | 75.91 Million USD | 93.565% |
| Bruker Corporation | 2.83 Billion USD | 99.828% |
| Cytosorbents Corporation | 29.98 Million USD | 83.709% |
| DexCom, Inc. | 4.19 Billion USD | 99.884% |
| Align Technology, Inc. | 2.45 Billion USD | 99.801% |
| Viveve Medical, Inc. | 10.84 Million USD | 54.965% |
| ZimVie Inc. | 795.85 Million USD | 99.386% |
| Movano Inc. | 5.97 Million USD | 18.202% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 95.33% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1048.652% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 59.149% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.236% |
| Profound Medical Corp. | 12.66 Million USD | 61.432% |
| Insulet Corporation | 1.85 Billion USD | 99.737% |
| enVVeno Medical Corporation | 2.43 Million USD | -100.616% |
| Surmodics, Inc. | 65.82 Million USD | 92.579% |
| iCAD, Inc. | 8 Million USD | 38.945% |
| Nuwellis, Inc. | 6.78 Million USD | 27.95% |
| Biotricity, Inc. | 35.91 Million USD | 86.4% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 97.81% |
| Aethlon Medical, Inc. | 2.47 Million USD | -97.004% |
| InspireMD, Inc. | 8.14 Million USD | 40.002% |
| PAVmed Inc. | 57.13 Million USD | 91.45% |
| BIOLASE, Inc. | 35.34 Million USD | 86.18% |
| Beyond Air, Inc. | 29.77 Million USD | 83.594% |
| FONAR Corporation | 57.45 Million USD | 91.498% |
| AxoGen, Inc. | 101.16 Million USD | 95.171% |
| Vivani Medical, Inc. | 25.03 Million USD | 80.488% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 94.436% |
| Inari Medical, Inc. | 209.32 Million USD | 97.666% |
| UFP Technologies, Inc. | 118.04 Million USD | 95.862% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 61.507% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -123.487% |
| Tenon Medical, Inc. | 5.56 Million USD | 12.251% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -174.592% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 72.298% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.845% |
| Sintx Technologies, Inc. | 6.59 Million USD | 25.906% |
| NanoVibronix, Inc. | 2.68 Million USD | -81.869% |
| Quanterix Corporation | 78.08 Million USD | 93.744% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -36.758% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.532% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.141% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 70.717% |
| NeuroMetrix, Inc. | 1.33 Million USD | -266.433% |
| Hyperfine, Inc. | 9.8 Million USD | 50.153% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 98.048% |
| Biomerica, Inc. | 2.66 Million USD | -83.44% |
| Bone Biologics Corporation | 831.4 Thousand USD | -487.562% |
| AVITA Medical, Inc. | 19.86 Million USD | 75.41% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -147.507% |
| Silk Road Medical, Inc | 114.15 Million USD | 95.721% |